Banco de Sabadell’s Bausch Health BHC Stock Holding History

Banco de Sabadell’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-135,721	Closed	-$2.07M	–	327
2020 Q3	$2.07M	Buy	+135,721	New	+$2.34M	0.23%	114

Other funds holding BHC

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

PIP

Permian Investment Partners Dallas, Texas $905M AUM 13.43% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Banco de Sabadell's BHC Position: Q4 2020 in Review

Banco de Sabadell sold out of Bausch Health (BHC) in Q4 2020, closing a stake of 135,721 shares — an estimated $2.07M sold.

Banco de Sabadell first reported a position in BHC in Q3 2020 and held it in 1 quarter. The position peaked at $2.07M in Q3 2020. 338 funds tracked by Wall St. Rank hold BHC as of Q4 2020.

Banco de Sabadell reported no remaining Bausch Health position as of Q4 2020 after selling out during the quarter.
Banco de Sabadell sold 135,721 Bausch Health shares in Q4 2020, an estimated $2.07M.
Banco de Sabadell first reported a position in Bausch Health in Q3 2020 and held it in 1 quarter.
Banco de Sabadell's Bausch Health position peaked at $2.07M in Q3 2020.
338 funds tracked by Wall St. Rank held Bausch Health as of Q4 2020.

Based on Banco de Sabadell's 13F filing for Q4 2020, filed 12 Feb 2021.